Market Insights
What’s causing the GT Biopharma, Inc. (GTBP) stock to experience downfall?
GT Biopharma, Inc. (GTBP) has experienced a downfall of 5.91% in the aftermarket. However, the last trading session concluded at $3.72. Demonstration of Novel B7-H3